TSE:BNS

Bank of Nova Scotia (BNS.TO)

112.36
-0.75 (0.66%)
as of Jun 5, 2026, 8:00:00 pm Market Open.
2156 watching
0
Investor Insights
star iconJun 5, 2026, 12:00 am

This summary was created by AI, based on 30 opinions in the last 12 months.

The Bank of Nova Scotia (BNS) has received mixed reviews from experts, highlighting its strong dividend yield and international focus, particularly in Latin America. While many analysts appreciate its valuation being relatively low compared to peers, there are concerns about strategic direction due to its recent investments. The bank is viewed positively for its turnaround potential under new management, yet some analysts caution about potential credit issues and the broader economic landscape affecting its performance. Overall, experts express a sense of cautious optimism, suggesting it is a solid long-term hold but emphasizing the importance of timing for new purchases.

consensus icon
Consensus
Hold
valuation icon
Valuation
Undervalued
review icon
Similar
RY
PAST TOP PICK
(A Top Pick Feb 01/22, Down 23%) It has under-performed the other banks. There is some concern over the international part of the business and large exposure to South America. Its sensitivity to changing interest rates is a little slow compared to others. Also there have been significant changes in management including the CEO who is from Finning, although he has been a director of BNS for a period of time. It is an excellent buy at these levels and has a 6% yield so wait for a recovery.
DON'T BUY
Not a favorite Canadian bank stock and believes there are better options available. Believes stock will under perform market. Latin America focus hurting the company.
BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Slower recovery due to weak Int’l markets. Trading cheaper than Canadian bank peers. Low rates will hurt short-term profits. Geographically focused in high ROE areas.
DON'T BUY
Really underperformed this quarter. BNS net interest rate margin didn't go up as much as the other banks, a worry. Used to like the international diversification, but that comes with a lot of risk. He likes TD much more.
WEAK BUY
BNS vs. CM Both have underperformed over the last year. CM is down 16%, BNS down 18%. RY is the only bank up YTD. Any contrarian would say buy. Over the last 5 years, both are at the bottom of the pack. If you like Latin America and the new CEO, pick BNS. If you think CM has cleaned up its US litigation, pick that one. BNS gets his vote. Yield is 6%.
TOP PICK
A reversion to the mean trade, so it will play catch up. Lagged its peers, but a very good bank. Uniquely, 45% of revenues from Latin America, an area that's growing faster than developed markets, despite recent softness. New CEO, opportunities for growth. Juicy yield of 5.99%. (Analysts’ price target is $79.15)
RISKY
Earnings season next week. Chronic underperformer last 5 years. Leadership transition. He'd prefer RY or BMO. If you believe in a turnaround, could be a value play for a patient investor, but not without uncertainty.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly Trading at only 9x earnings and under 1.25x book value, BNS is reiterated as a TOP PICK. Market analysts have already factored in a reduction in quarterly earnings, leaving more likelihood for a positive earnings surprise later this month -- especially as higher interest rate allow for higher profit margin for them. Longer term, its investments into South America, will differentiate it from its peers as economic growth in that region outpaces that of Canada and US in the years ahead. It pays a great dividend, backed by a payout ratio under 50% of cash flow. We recommend trailing up the stop loss (from $61.50) to $63.00, targeting $85 -- upside potential over 18%. Yield 5.8% (Analysts’ price target is $84.21)
BUY ON WEAKNESS
Currently owns shares in the company. Long term, believes business is a good investment. Strong franchise with a healthy balance sheet. New CEO not from banking sector (market does not like that). Believes dividend is safe and company will sort itself out. Current share price presenting discount to peers.
BUY
At 8x earnings, discount to historical range and to its peers. TD is 10x, RY is 11x, CM and BMO are 9x. Struggles in recent years, mainly due to international operations. CEO from outside signals desperate times. See his Top Picks.
TOP PICK
Like a Dogs of the Dow scenario. Highest yield of the Big 5, which have never cut a dividend, so dividend is rock solid. 8x earnings. If stock can appreciate just 3-4% annually, that's a 10% total annualized return. Senior executive turnaround and repairs needed provide the opportunity. Hard to put down Canadian banks. Yield is 6%. (Analysts’ price target is $83.11)
PARTIAL BUY
Every cycle of rate hiking gets hit by some credit-driven catastrophe, a cloud on banks. Cheap, adjusted book value is $97. In shorter term, something will erupt to pull down the sector and give you a chance to steal the stock. Nice yield. Could buy here in bits and pieces every quarter.
DON'T BUY
Promise of faster, secular growth in emerging markets has never really materialized. Buy you still get all the volatility, credit risk, regime change, currency risk. Risk and reward are supposed to be 2 parts of the same coin, so if you have greater risk but not commensurate reward, probably not a great investment, especially relative to peers.
BUY
CEO changeover controversy is just a lot of noise that doesn't detract from overall story. SA exposure has hurt. Overall in good shape, competitively priced against other Canadian banks, extremely good yield. A Buy.
BUY
Likes Canadian banks stocks. Recent selloff has sold of shares at ~30%. Controversial CEO change recently. Very steady business with excellent capitalization. History of Canadian banks very strong.
Showing 166 to 180 of 1,688 entries